Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

1.92
Delayed Data
As of 3:53pm ET
 +0.08 / +4.35%
Today’s Change
1.79
Today|||52-Week Range
3.82
-8.13%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close1.84
Today’s open1.85
Day’s range1.82 - 1.96
Volume193,402
Average volume (3 months)33,283
Market cap$31.6M
Dividend yield--
Data as of 3:53pm ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)+42.50%
Earnings growth (this year)-4.75%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book0.94

Competitors

 Today’s
change
Today’s
% change
SBOTStellar Biotechnolog...-0.07-2.25%
CTRVContraVir Pharmaceut...-0.02-2.40%
PULMPulmatrix Inc+0.18+8.70%
MRNSMarinus Pharmaceutic...+0.01+0.58%
Data as of 3:59pm ET, 07/27/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$5.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
James Garner
Chief Financial Officer
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts

Partner Offers

Search for Jobs